Ligandrol/LGD-4033

Ligandrol (LGD-4033) Overview

Ligandrol, also known as LGD-4033 or VK5211, is a non-steroidal selective androgen receptor modulator (SARM) developed to treat muscle-wasting conditions and osteoporosis. It binds selectively to androgen receptors in muscle and bone tissues, promoting anabolic activity without significantly affecting other organs.

Mechanism of Action

Ligandrol functions by binding to androgen receptors in muscle and bone, stimulating protein synthesis and muscle growth. Its selectivity minimizes unwanted effects on other tissues, such as the prostate or liver

Dosage and Administration

• Typical Dosage: 5–10 mg per day.

• Cycle Length: 6–10 weeks.

• Administration: Orally, once daily.​

Potential Benefits

• Increased Lean Muscle Mass: Users report gains of 5–10 pounds over an 8-week cycle.

• Enhanced Strength and Endurance: Improved performance in resistance training.

• Fat Loss: Preserves muscle mass during caloric deficits.

• Bone Health: Potential benefits in increasing bone density.